Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 8

Evaluation of clinicopathological characteristics andprognosis of lung ınvasive mucinous adenocarcinomasbased on computed tomography (CT) findings

Pages
1445–1449
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Based on CT findings, pneumonic type-IMA was associated with a more advanced stage (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: The aim of our study is to evaluate the cases with invasive mucinous adenocarcinoma (IMA) detected separately from lung adenocarcinoma in the 2015 WHO classification and to associate the clinicopathological findings and evaluate their prognostic significance based on computed tomography (CT) findings.Materials and Methods: The materials of patients who underwent resection from January 1 2011 to June 31 2019 at our hospital were reviewed after archive screening and those belonging to the Invasive mucinous adenocarcinoma group were determined according to the WHO 2015 classification.
📊
Key Findings & Data:Tumors were classified as solitary or pneumonic type based on CT findings, and the data obtained were compared statistically.Results: Based on CT findings (pneumonic and solitary), pathological T stages were significantly different between the two groups.
💡
Conclusion & Impact:Based on CT findings, pneumonic type-IMA was associated with a more advanced stage (p
🔬Design:Review & Systematic Survey
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: The aim of our study is to evaluate the cases with invasive mucinous adenocarcinoma (IMA) detected separately from lung adenocarcinoma in the 2015 WHO classification and to associate the clinicopathological findings and evaluate their prognostic significance based on computed tomography (CT) findings.Materials and Methods: The materials of patients who underwent resection from January 1 2011 to June 31 2019 at our hospital were reviewed after archive screening and those belonging to the Invasive mucinous adenocarcinoma group were determined according to the WHO 2015 classification. Clinical and radiological data of the cases were collected. Tumors were classified as solitary or pneumonic type based on CT findings, and the data obtained were compared statistically.Results: Based on CT findings (pneumonic and solitary), pathological T stages were significantly different between the two groups. Based on CT findings, pneumonic type-IMA was associated with a more advanced stage (p

🔖

Cite This Article

ÜRER, H. N., ÜNVER, N., FENER, N. A. (2022). Evaluation of clinicopathological characteristics andprognosis of lung ınvasive mucinous adenocarcinomasbased on computed tomography (CT) findings. Annals of Medical Research, Cilt: 28 - Sayı: 8, 1445–1449. https://ajindex.com/articles/445722

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Nie K, Nie W, Zhang YX, et al. Comparing clinicopathological features and prognosis of primary pulmonary invasive mucinous adenocarcinoma based on computed tomography findings. Cancer Imaging 2019
  2. 47 2. Suárez-Piñera M, Belda-Sanchis J, Taus A, et al. FDG PET-CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value. Am J Nucl Med Mol Imaging 2018
  3. Moon SW, Choi SY, Moon MH. Effect of invasive mucinous adenocarcinoma on lung cancer-specific survival after surgical resection: a population-based study. J Thorac Dis 2018:3595-608. 4. Lee HY, Cha MJ, Lee KS, et al. Prognosis in Resected Invasive Mucinous Adenocarcinomas of the Lung: Related Factors and Comparison with Resected Nonmucinous Adenocarcinomas. J Thorac Oncol 2016
  4. 73 5. Travis WD, Brambilla E, Nicholson AG, et al. WHO Panel. The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification. J Thorac Oncol 2015
  5. Sun F, Wang P, Zheng Y, et al. Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma. Oncol Lett 2018
  6. Yoshizawa A, Motoi N, Riely GJ, et al. Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011
  7. Watanabe H, Saito H, Yokose T, et al. Relation between thin-section computed tomography and clinical findings of mucinous adenocarcinoma. Ann Thorac Surg 2015
  8. Cha MJ, Lee KS, Kim TJ, et al. Solitary Nodular Invasive Mucinous Adenocarcinoma of the Lung: Imaging Diagnosis Using the Morphologic-Metabolic Dissociation Sign Korean J Radiol 2019
  9. Yoshizawa A, Sumiyoshi S, Sonobe M, et al. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. J Thorac Oncol 2013
  10. Shim HS, Kenudson M, Zheng Z, et al. Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung. J Thorac Oncol 2015
  11. Shimizu K, Okita R, Saisho S, et al. Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings. Onco Targets Ther 2016
  12. Koo HJ, Kim MY, Koo JH, et al. Computeri